Introduction
The activation of G-protein coupled receptors results in a cascade of processes and different agonists acting on a single receptor can result in varying signaling patterns (Urban et al., 2007) . The mu-opioid receptor (MOR) is a G i/o -linked receptor that activates a potassium conductance, inhibits voltage dependent calcium conductance and inhibits adenylyl cyclase (Williams et al., 2001 ). In the continued presence of agonist, the MOR desensitizes by a mechanism that is thought to be similar to that originally described for the ß-adrenergic receptor (Krupnick and Benovic, 1998; Lefkowitz et al., 1998) . The first step in receptor desensitization is thought to be a phosphorylation of the receptor by a G protein-coupled receptor kinase (GRK) followed by the binding to ß-arrestin with high affinity. This process also transforms the receptor into a state where it can no longer couple to G proteins and is therefore physiologically inactive. Acute desensitization can take place within a few minutes and requires a saturating concentration of agonist (Connor et al., 2004; Gainetdinov et al., 2004; vonZastrow et al., 2003) .
Like the ß-adrenergic receptor, the MOR is trafficked into early endosomes followed by a multi-step process that recycles receptor back to the plasma membrane (Finn and Whistler, 2001; Tanowitz and vonZstrow, 2003) . This trafficking pathway has been hypothesized to be a critical step in the recovery from desensitization where phosphatase activity is necessary for the reinsertion of receptors into the plasma membrane (vonZastrow et al., 2003; Ferguson et al., 1998; Luttrell and Lefkowitz 2002; Marie et al., 2006) . The trafficking of MOR has been characterized in a variety of This article has not been copyedited and formatted. The final version may differ from this version. Receptor activation, desensitization and internalization have different concentration dependence or require distinct agonist/receptor dwell times. In order to understand the complexity of signaling from a single receptor it is necessary to study two or more processes simultaneously or at least under identical conditions with a variety of agonists. This study measured acute signal transduction (membrane hyperpolarization), acute desensitization and receptor internalization resulting from the activation of an epitope-tagged MOR in a brain slice preparation.
Materials and Methods
FlagMOR-transgenic mice: The transgene was constructed by first ligating an 8.5 kb genomic fragment of the rat TH gene from plasmid pTH9000 (Min et al., 1994) containing 5' regulatory sequences, the basal promoter, and 26 bp from the 5' UTR in exon 1 of TH to a 0.7 kb cassette containing a heterologous intron 2 and splice donor/acceptor sites from the rabbit ß-globin gene. The 2.2 kb Flag epitope-tagged MOR cDNA with a bovine growth hormone polyA sequence was obtained from excision of plasmid pcDNA3 SSF-MOR (Kim and vonZastrow, 2003) and ligated 3' to the ß-globin intron in a pBluescript SK+ plasmid vector. The Flag epitope (DYKDDDA) is immediately preceded by a modified influenza hemaglutinin signal peptide sequence that facilitates translocation of the modified receptor into the endoplasmic reticulum and production of functional protein. Co-translational cleavage of this sequence by signal peptidase is essential for subsequent binding of the M1 antibody to the free aminoThis article has not been copyedited and formatted. The final version may differ from this version. terminal end of the Flag epitope. An 11.4 kb SalI-NotI transgene fragment was purified from the final construct and used for pronuclear microinjection into zygotes of B6D2 F 2 mice by standard techniques. Two independent founders were identified by PCR genotyping of genomic DNA and backcrossed with C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) to obtain N 1 hemizygous progeny for initial characterization. The one strain with readily detectable levels of FlagMOR by immunofluoresence in brain slices was further maintained by continued backcrossing with C57BL/6J mice. All data were collected from these hemizygous FlagMOR-Tg/+ mice ranging from generations N 1 to N 5 . FlagMOR-Tg/+ mice were also crossed with MOR (Schuller et al., 1999) and ß-arrestin2 knockout mice (Bohn et al., 2000) to generate mice that were hemizygous for the FlagMOR transgene and homozygous for either the MOR-KO (FlagMOR-Tg/+, MOR-/-) or the ß-arrestin2-KO (FlagMOR-Tg/+, Arr-/-).
All animal experiments were conducted in accordance with the National Institutes of Health guidelines and with approval from the Institutional Animal Care and Use Committee of the Oregon Health & Science University. Fluorescent immunohistochemistry: Fixed brains from FlagMOR-Tg/+ mice perfused with 4% paraformaldehyde were prepared and sliced to 50 µm using a vibratome (Leica, Nussloch, Germany) as described previously (Ford et al., 2006) . The primary antibody against the Flag epitope (M1, Sigma, St. Louis, MO) was chemically linked to Alexa 555 (monoclonal labeling kit, Molecular Probes, Eugene, OR) and used at a 1:500 dilution. Immunostaining was done using a free-floating method and tissue slices were incubated at 4˚C for 18 hours. For tyrosine hydroxylase co-localization experiments, the tissues were permeabilized with 0.4% Triton X. The primary antibody This article has not been copyedited and formatted. The final version may differ from this version. Electrophysiolgy: Adult mice (4-10 weeks) were used for electrophysiology experiments. Animals were anesthesized with isoflurane, the brain was removed and sliced horizontally using a vibratome (Leica, Nussloch, Germany) in ice-cold artificial . Drugs were applied by perfusion at the rate of 1.5 ml/min. Two-photon microscopy: Brain slices (200-220 µM) were prepared as those described for electrophysiological experiments. Slices were incubated in a solution containing M1 antibody (Sigma, St Louis MO) conjugated with Alexa 594 (Molecular Probes, Eugene, OR, 10 µg/ml, 45-60 min). In previous work the behavior of antibodytagged receptors with unlabeled receptors was compared and there was no significant difference between the two conditions on the time scale of an hour (Tanowitz and vonZastrow, 2003; Whistler et al., 1999 (Pologruto et al., 2003) . A z-series was collected at 1 µm intervals for 15 µm. Drugs were applied by perfusion. All experiments were done at 35˚C. Drugs used were ME, oxycodone Radioligand binding assay: Slices containing the locus coeruleus nuclei were prepared (~500 µm) and the area of the LC was dissected. The tissue was homogenized using a Dounce Tissue Grinder in ice-cold Tris HCl (50 mM, pH 7.4). Tissue from 6-10 animals was prepared for a binding assay using
Pittsburgh, PA) as described previously (Bunzow et al., 1995) . Analyses were done using a one-site binding hyperbolic equation from Graph Pad Prism (San Diego, CA).
Results

FlagMOR-transgenic mice
A transgenic mouse strain was generated that expresses a fusion protein consisting of the MOR with an amino-terminal Flag epitope targeted to catecholamine neurons by an 8.5 kb segment of genomic DNA from the rat tyrosine hydroxylase (TH) gene ( Figure 1A ). Staining of FlagMOR on the plasma membrane of locus coeruleus (LC) neurons was demonstrated using the M1-antibody conjugated with Alexa 555 and was limited to the area of LC and co-localized with TH immunoreactivity ( Figure 1B ).
The FlagMOR was also detected in other catecholamine neurons in the olfactory bulb, arcuate nucleus, substantia nigra and ventral tegmental area (not shown). There was no obvious phenotypic difference between the transgenic mice and their wild type littermates. Hemizygous FlagMOR-Tg/+ mice grew and bred normally.
Opioid receptor expression and function
Receptor number determined by a binding assay using opioid receptor (DOR) fused to EGFP (Scherrer et al., 2006) . In homozygous DOR-EGFP knockin mice there was about a 2-fold increase in binding sites and a 3-fold increase in GTP-gamma-S binding (Scherrer et al., 2006) .
Functional coupling of opioid receptors to a G protein-linked inwardly rectifying potassium channel (GIRK) was measured by intracellular recording of membrane potential in LC neurons ( Figure 1C ). The maximal hyperpolarization induced by [Met 5 ]enkephalin (ME, 30 µM) was 30.1±1.3 mV and 28.8±1.1 mV in FlagMOR-Tg/+ and wild type mice (n=14 and 19 neurons, respectively, t-test P>0.05, Figure 1D ). The membrane hyperpolarization induced by the alpha 2 -adrenoceptor agonist, UK14304 (3 µM) was also the same in transgenic and wild type mice (FlagMOR-Tg/+=23.9±1.6 mV, n=14, wild type=25.8±0.9 mV, n=24, t=test P>0.05) suggesting that the higher receptor numbers in FlagMOR-Tg/+ neurons did not interfere with activity of GIRK. Increased receptor expression in FlagMOR-Tg/+ mice did, however result in an increase in the potency of ME. There was a 7-fold leftward-shift in the EC 50 in recordings made from slices taken from FlagMOR-Tg/+ mice compared to wild type (FlagMOR-Tg/+ EC 50 =94 nM; wild type EC 50 =658 nM; Figure 1D ).
Hemizygous FlagMOR-Tg/+ mice were crossed with MOR knockout (MOR-/-) FlagMOR-Tg/+, MOR-/-mice was 151 nM, 50% greater than that in the FlagMOR-Tg/+ mice (94 nM) and only 4-fold less than the EC 50 of wild type animals (658 nM, Figure   1D ).
FlagMOR internalization in brain slices
A useful feature of the detection system combining a Flag-epitope tagged receptor and M1 antibody is that the binding affinity between the two is decreased considerably upon the removal of calcium from the extracellular buffer. Slices were prepared identically to those used for electrophysiological experiments, incubated with the fluorescent-M1 antibody for 45 min and then placed in a tissue bath on the microscope for imaging. The fluorescent outlines of cell bodies were first visualized in each experiment (control, Figure 2A ). When the superfusion solution was changed to one that was calcium free (EGTA 0.5 mM) for 10 min and the cells were imaged again, staining on the plasma membrane decreased to background levels ( Figure 2A ). This result confirmed that the fluorescence seen surrounding the cell body required calcium and that a 10 min wash with calcium free solution eliminated specific staining. In the next experiment an initial image was taken following staining and a second image was taken after treatment of the slice first with ME (30 µM, 15 min) followed by calcium free (EGTA) solution (10 min). The resulting image showed numerous fluorescent puncta remaining within the soma and processes ( Figure 2C and D). To determine if the ME induced increase in intracellular puncta was receptor dependent, slices were treated with the irreversible opioid antagonist, ß-chlornaltrexamine (ß-CNA, 500 nM, 2 min) before the application of ME (30 µM, 15 min). The slice was then treated with calcium free This article has not been copyedited and formatted. The final version may differ from this version. (EGTA) solution and the result was a complete block of receptor internalization ( Figure   2B , EGTA wash without ME treatment = 34.2±2.9 %, n=6; EGTA wash post ß-CNA+ME -38.7±4.3%, n=3). The results indicate that the appearance of intracellular fluorescent puncta within the cell was dependent on the activation of FlagMOR.
The concentration dependence of internalization induced by ME was determined in slices from FlagMOR-Tg/+, MOR-/-mice ( Figure 4) . Application of ME (300 nM)
did not result in an accumulation of fluorescence that was different from control. At higher concentrations (3 and 10 µM) more intracellular fluorescence was observed and the concentration that was required to cause a half-maximal amount of internalization was about 3 µM, well above the EC 50 (151 nM) for the hyperpolarization. Thus the concentrations of ME required to induce desensitization and internalization were significantly greater than that required to induce hyperpolarization (Harris and Williams, 1991) indicating that less receptor occupancy is required to mediate the activation of the potassium current.
The time course of accumulation of intracellular fluorescence was examined by capturing images at 3 min intervals following the onset of superfusion with ME (30 µM, To determine if FlagMOR activity was regulated similarly to native receptors, desensitization was induced by a saturating concentration of ME (30 µM, 10 min). Prior to the application of the desensitizing concentration of ME, a pre-pulse of ME (EC 50 ) was applied and the amplitude of the hyperpolarization was measured. Desensitization was measured in two ways. The first was to measure the decline in the peak hyperpolarization that occurred during the 10 min perfusion of ME (30 µM, Figure 5A ).
The amplitude of the hyperpolarization after 10 minutes decreased to 70%, 79% and 76%
of the peak in wild type, FlagMOR-Tg/+, and FlagMOR-Tg/+, MOR-/-mice, respectively ( Figure 5B , ANOVA P>0.05). Second, the amplitude of the hyperpolarization induced by an EC 50 concentration of ME tested 5 min after washout of the desensitizing concentration of ME was decreased to 38±3% of the pre-pulse amplitude in wild type (ME 300 nM, n=9 neurons), 35±6% in FlagMOR-Tg/+ (ME 100 nM, n=5) and 40±7% in FlagMOR-Tg/+, MOR-/-(ME 100 nM, n=5, ANOVA P>0.05) mice.
The time-course of recovery from desensitization was measured by repeated applications of ME (100 or 300 nM) over a 30 min period ( Figure 5A and C). All three genotypes showed a similar extent and time course of recovery from desensitization (ANOVA P>0.05). Thus, FlagMORs were functional and regulated similarly to endogenous receptors.
Recycling of receptors was observed in experiments where the preparation was treated with ME (30 µM, 5 min), followed by a wash with calcium free EGTA buffer ( Figure 5D ). Thus the FlagMOR/fluorescent-M1 bound complex was capable of recycling in a time frame similar to the recovery from desensitization. Although only a fraction of the internalized receptors were able to traffic back to plasma membrane, the hyperpolarization induced by ME recovered almost completely. It is likely that the percentage of receptors that return to the plasma membrane is sufficient to result in a maximal hyperpolarization. The receptor-reserve reported in LC neurons suggests that only a small percentage of total receptors is necessary to elicit a maximal response (Christie et al., 1987) .
Agonist-dependence of MOR desensitization and internalization
A series of opioid agonists was examined for the ability to induce desensitization and internalization in LC slices ( Figure 6 ). As has been reported in other systems, ME, methadone and etorphine were all effective receptor-internalizing agents. The percent internalization induced by ME (30 µM) was 35±8% (n=6), etorphine (1 µM) 44±9% (n=6), and methadone (15 µM) 30±6% (n=6). The internalization induced by morphine (6±3%, n=6), oxymorphone (5±5%, n=6) and oxycodone (2±4%, n=6) was not different from background.
The ability of each opioid agonist to induce hyperpolarization and acute desensitization were also compared ( Figure 6B and C) . Each of the agonists produced a similar maximal hyperpolarization. Desensitization was measured as the decline in the amplitude of the hyperpolarization induced by each agonist during a 15 min application of a saturating concentration. The washout of all agonists except ME was very slow, so reversal of the hyperpolarization was obtained with the perfusion of naloxone (1 µM).
This article has not been copyedited and formatted. The final version may differ from this version. Following return of the membrane potential to control the alpha-2-adrenoceptor agonist, UK14304 (3 µM) was perfused and the amplitude of the resulting hyperpolarization was measured. During a 15-minute application of ME (30 µM despite the fact that the maximum hyperpolarization was reduced (13.5±0.9 mV).
Internalization induced by ME was examined in slices from FlagMOR-Tg/+, Arr-/-animals. Slices from these mice were treated with ME (30 µM, 15 min) and the percent internalization calculated. Internalization of FlagMOR did not differ between littermates lacking or expressing ß-arrestin2 (FlagMOR-Tg/+, Arr-/-=28±3%, n=9 neurons;
FlagMOR-Tg/+=26±5%, n=10, see Figure 7A and C). Thus elimination of ß-arrestin2 had no effect on desensitization or internalization.
Discussion
In the present study, brain slices from transgenic mice were used to examine desensitization and trafficking of mu opioid receptors. Epitope-tagged (Flag) mu opioid receptors (FlagMOR) were targeted to locus coeruleus neurons using regulatory elements from the tyrosine hydroxylase gene. Using ME, the FlagMOR was activated and regulated in a similar way as the endogenous receptor. A series of opioid agonists was used to determine if different agonists activated distinct pathways. All agonists activated a potassium conductance that resulted in the same maximum hyperpolarization. The demonstration of agonist-selective regulation of desensitization and internalization indicates that the two processes are independent and are not necessarily serial events.
Originally, morphine was described as the agonist that caused neither desensitization nor This article has not been copyedited and formatted. The final version may differ from this version. internalization (Alvarez et al., 2002) , however recent results indicate that it can cause both desensitization (Borgland et al., 2003; Dang and Williams, 2005) and internalization (Haberstock-Debic et al., 2005) . In contrast, the present results based on brain slices containing LC neurons show that morphine causes desensitization but no internalization.
Oxymorphone was similar to morphine in that it caused robust desensitization in LC neurons from rats (Virk and Williams, 2008) and mice but was ineffective at evoking internalization of FlagMOR. The processes of internalization and desensitization have also been separated in experiments using cultured neurons treated with concanavalin A, where desensitization induced by ME and a dermorphin analog (dermorphin-Alexa 594)
was induced in the absence of internalization (Arttamangkul et al., 2006) . Thus it appears that although desensitization may be a precursor to internalization, internalization is not necessary for the expression of desensitization.
The agonists used in this study produced three distinct classes of effects. One group caused both desensitization and internalization and included ME, etorphine and methadone. Morphine and oxymorphone were distinct in that neither caused detectable internalization but both were capable of inducing desensitization. Oxycodone was the only agonist that neither desensitized nor internalized the receptor. In spite of the fact that oxycodone and oxymorphone differ only in a single methyl group, there was a distinct functional difference between the two compounds. Oxymorphone was more efficacious and much more effective at inducing desensitization than oxycodone (Virk and Williams, 2008) . Given that oxymorphone is a natural metabolite of oxycodone, the This article has not been copyedited and formatted. The final version may differ from this version. receptor dependent processes of both oxycodone and oxymorphone must be considered in vivo.
The only way that desensitization could be compared using a series of agonists was by measuring the decline in the hyperpolarization during an extended application of a saturating concentration of each agonist. The slow washout of most agonists from brain slices prevented a more quantitative measurement of a decrease in sensitivity that was possible with ME ( Figure 5A , 6B). The decline in peak hyperpolarization is not the most sensitive assay, as receptor reserve and the different efficacy of agonists result in a variable amount of desensitization. Given that near saturating concentrations of agonist are required for both desensitization and internalization, the decline in peak hyperpolarization would be blunted in experiments where highly efficacious agonists, such as ME or etorphine, were examined. Thus although a quantitative measure of desensitization is not possible, the rank order of the ability of various agonists to induce desensitization was reliably determined with this measure.
Morphine, oxymorphone and oxycodone are small opiate alkaloids having morphinan base structure while ME and methadone are linear and more flexible compounds. Considering the widely varying differences in chemical structure of opioid agonists, one may predict that different agonists could stabilize a range of receptor conformations and thus differentially affect the mechanisms leading to desensitization and internalization. Similar agonist dependent effects on receptor trafficking of ß2-adrenoceptors (Swaminath et al., 2005) and dopamine D1 receptors (Ryman-Rasmussen This article has not been copyedited and formatted. The final version may differ from this version. Morphine is a good example in that it does not cause mu opioid receptor internalization in many cell types but did in cultured striatal neurons (Haberstock-Debic et al., 2005) . It is also known that morphine can cause internalization in a system where G-protein receptor kinase (GRK) is over expressed . Although phospho-MOR preferentially interacts with and has higher affinity to ß-arrestin2 than ß-arrestin1 (Bohn et al., 2000; Bohn et al, 2004; Oakley et al., 2000) the results with the ß-arrestin2 KO mice suggest a possible interaction with ß-arrestin1. It is clear that mice lacking ß-arrestin2 have a dramatically altered response to some opioids. For example the tolerance to morphine is reduced, but treatment with etorphine resulted in tolerance that was the same as in wild-type animals . These results are consistent with the idea that agonists can produce different patterns of receptor signaling in vivo (Stafford et al., 2001 ).
Although little work has been done at the cellular level with neurons from the ß-arrestin2 knockout mice, the results in the present study are consistent with other studies that have reported that acute desensitization induced by opioid peptide agonists was not changed in either cultured dorsal root ganglion cells (Walwyn et al., 2007) or in LC neurons recorded in brain slices (Dang and Christie, personal communication) . That desensitization and internalization of FlagMOR were both observed in brain slices from ß-arrestin2 knockout mice suggests that mu opioid receptor signaling can occur by redundant pathways such that the control of receptor dependent signaling is ensured.
This article has not been copyedited and formatted. The final version may differ from this version. perfusion of ME (30 µM, n=4). The fluorescence ratio was determined by dividing the counts measured after the addition of ME by the counts in the same area before addition of ME. Fluorescence decreased at the plasma membrane (2 µm, grey diamonds) and increased in the interior of the cell (3-6 µm, solid squares). induced by ME (300 nM) before and after treatment of the slice with ME (30 µM) for 10 min. Following the washout of ME (30 µM) the hyperpolarization induced by ME (300 nM) was depressed and recovered completely after 30 min. At the end of the recording a saturating concentration of UK14304 (3 µM), an alpha-2-adrenoceptor agonist, and its blockade by the antagonist yohimbine (Yoh), was tested. B. Summary of the change in membrane potential during the 10-min treatment with ME (30 µM). The results indicate that the decline in the hyperpolarization was the same in slices from all three genotypes.
C. Summary of the time course and extent of recovery from desensitization. There was no difference between genotypes. Given that the FlagMOR-Tg/+ and FlagMOR-Tg/+ MOR-/-were more sensitive to ME, the test concentration used to measure the recovery This article has not been copyedited and formatted. The final version may differ from this version. 
